Dimethylformamide → 1-Methyl-1H-imidazole-4-sulfonic Acid [4-(4-amino-pyrazolo[3,4-d]pyrimidin-1-yl)-phenyl]-amide

HRID 655855

반응식

HRID 655855 반응식
[NH2:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:12]3=[N:13][CH:14]=[N:15][C:16]([NH2:17])=[C:11]3[CH:10]=[N:9]2)=[CH:4][CH:3]=1.C[N:19]1C=CN=[C:20]1[S:24](Cl)(=[O:26])=[O:25].C(N(C(C)C)CC)(C)C.[CH3:37][N:38]([CH:40]=O)[CH3:39]>CO>[NH2:17][C:16]1[N:15]=[CH:14][N:13]=[C:12]2[N:8]([C:5]3[CH:6]=[CH:7][C:2]([NH:1][S:24]([C:20]4[N:19]=[CH:37][N:38]([CH3:39])[CH:40]=4)(=[O:26])=[O:25])=[CH:3][CH:4]=3)[N:9]=[CH:10][C:11]=12

참가 물질

6

실험 절차

Title compound 11A, 1-(4-amino-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine (33 mg, 1.0 eq, 0.15 mmol), 1-methylimidazole sulphonylchloride (22 mg, 1.0 eq, 0.15 mmol) and diisopropylethylamine (23 μl, 0.9 eq, 0.13 mmol) were added to DMF (1 ml) and the mixture was stirred for 48 hours at room temperature under an inert atmosphere. Methanol was then added (1 ml) and the solvents were removed in vacuo. The resultant residue was purified column chromatography using DCM/MeOH (96:4) as eluen followed by trituration in methanol to yield the title compound as a white solid (6 mg, 0.03 mmol, 11%). LCMS: [M+H]+=371, Rt=1.33 min, 100% purity.

후처리

  1. customthe solvents were removed in vacuo
  2. customThe resultant residue was purified column chromatography

출처 및 근거

ORD 기록
ord-ba642d489c804223a93dd2a4954d93bf
출처 데이터셋
uspto-grants-2011_12
특허 번호
US08071607B2

연결된 노트

불러오는 중…